{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:46:03Z","timestamp":1790790363484,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      While lung transplant (LTX) can be an effective therapy to provide the survival benefit in selected populations, post-transplant outcome in LTX recipients with bronchiectasis other than cystic fibrosis (CF) has been less studied.\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      , often associated with exacerbations in bronchiectasis, is the most common micro-organism isolated from LTX recipients. We aimed to see the outcomes of patients with bronchiectasis other than CF after LTX and seek the risk factors associated with pre- and post-transplant\n                      <jats:italic>Pseudomonas<\/jats:italic>\n                      status.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Patients who underwent LTX at Tohoku University Hospital between January 2000 and December 2020 were consecutively included into the retrospective cohort study. Pre- and post-transplant prevalence of\n                      <jats:italic>Pseudomonas<\/jats:italic>\n                      colonization between bronchiectasis and other diseases was reviewed. Post-transplant outcomes (mortality and the development of chronic lung allograft dysfunction (CLAD)) were assessed using a Cox proportional hazards and time-to-event outcomes were estimated using the Kaplan\u2013Meier method.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      LTX recipients with bronchiectasis experienced a high rate of pre- and post-transplant\n                      <jats:italic>Pseudomonas<\/jats:italic>\n                      colonization compared to other diseases with statistical significance (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001, respectively). Nevertheless, long-term survival in bronchiectasis was as great as non-bronchiectasis (Log-rank\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.522), and the bronchiectasis was not a trigger for death (HR 1.62, 95% CI 0.63\u20134.19). On the other hand, the chance of CLAD onset in bronchiectasis was comparable to non-bronchiectasis (Log-rank\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.221), and bronchiectasis was not a predictor of the development of CLAD (HR 1.88, 95% CI 0.65\u20135.40).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Despite high prevalence of pre- and post-transplant\n                      <jats:italic>Pseudomonas<\/jats:italic>\n                      colonization, the outcome in LTX recipients with bronchiectasis other than CF was comparable to those without bronchiectasis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-021-01634-z","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T23:34:15Z","timestamp":1628811255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Outcome and prognostic factors after lung transplantation for bronchiectasis other than cystic fibrosis"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9390-5057","authenticated-orcid":false,"given":"Takashi","family":"Hirama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5041-4231","authenticated-orcid":false,"given":"Fumiko","family":"Tomiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4601-2528","authenticated-orcid":false,"given":"Hirotsugu","family":"Notsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9104-6175","authenticated-orcid":false,"given":"Tatsuaki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0155-8754","authenticated-orcid":false,"given":"Yui","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1381-6362","authenticated-orcid":false,"given":"Hisashi","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7739-7657","authenticated-orcid":false,"given":"Yoshinori","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,13]]},"reference":[{"key":"1634_CR1","doi-asserted-by":"publisher","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","volume":"50","author":"E Polverino","year":"2017","unstructured":"Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50:1700629.","journal-title":"Eur Respir J."},{"key":"1634_CR2","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/resp.13509","volume":"24","author":"A Bush","year":"2019","unstructured":"Bush A, Floto RA. Pathophysiology, causes and genetics of paediatric and adult bronchiectasis. Respirology. 2019;24:1053\u201362.","journal-title":"Respirology"},{"issue":"Suppl 1","key":"1634_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","volume":"74","author":"AT Hill","year":"2019","unstructured":"Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Stuart Elborn J, Andres Floto R, et al. British thoracic society guideline for bronchiectasis in adults. Thorax. 2019;74(Suppl 1):1\u201369.","journal-title":"Thorax"},{"key":"1634_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.healun.2014.06.014","volume":"34","author":"D Weill","year":"2015","unstructured":"Weill D, Benden C, Corris PA, Dark JH, Davis RD, Keshavjee S, et al. A consensus document for the selection of lung transplant candidates: 2014\u2014an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Hear Lung Transplant. 2015;34:1\u201315.","journal-title":"J Hear Lung Transplant"},{"key":"1634_CR5","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.healun.2016.09.001","volume":"35","author":"RD Yusen","year":"2016","unstructured":"Yusen RD, Edwards LB, Dipchand AI, Goldfarb SB, Kucheryavaya AY, Levvey BJ, et al. The registry of the international society for heart and lung transplantation: thirty-third adult lung and heart-lung transplant report\u20142016; focus theme: primary diagnostic indications for transplant. J Hear Lung Transplant. 2016;35:1170\u201384.","journal-title":"J Hear Lung Transplant"},{"key":"1634_CR6","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.transproceed.2019.04.036","volume":"51","author":"V Rusanov","year":"2019","unstructured":"Rusanov V, Fridman V, Wille K, Kramer MR. Lung transplantation for cystic fibrosis and non-cystic fibrosis bronchiectasis: a single-center experience. Transplant Proc. 2019;51:2029\u201334.","journal-title":"Transplant Proc"},{"key":"1634_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.chest.2020.01.056","volume":"158","author":"T Hirama","year":"2020","unstructured":"Hirama T, Singer LG, Brode SK, Marras TK, Husain S. Outcomes of a peri- and postoperative management protocol for non-TB mycobacteria in lung transplant recipients. Chest. 2020;158:523\u20138.","journal-title":"Chest"},{"key":"1634_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/tri.13540","volume":"33","author":"J Raskin","year":"2020","unstructured":"Raskin J, Vanstapel A, Verbeken EK, Beeckmans H, Vanaudenaerde BM, Verleden SE, et al. Mortality after lung transplantation: a single-centre cohort analysis. Transpl Int. 2020;33:130\u201341.","journal-title":"Transpl Int"},{"key":"1634_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3390\/genes11060589","volume":"11","author":"V Scotet","year":"2020","unstructured":"Scotet V, L\u2019hostis C, F\u00e9rec C. The changing epidemiology of cystic fibrosis: Incidence, survival and impact of the CFTRGene discovery. Genes (Basel). 2020;11:589.","journal-title":"Genes (Basel)"},{"key":"1634_CR10","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/00005176-199705000-00010","volume":"24","author":"Y Yamashiro","year":"1997","unstructured":"Yamashiro Y, Shimizu T, Oguchi S, Shioya T, Nagata S, Ohtsuka Y. The estimated incidence of cystic fibrosis in Japan. J Pediatr Gastroenterol Nutr. 1997;24:544\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1634_CR11","doi-asserted-by":"publisher","first-page":"190048","DOI":"10.1183\/16000617.0048-2019","volume":"28","author":"H Richardson","year":"2019","unstructured":"Richardson H, Dicker AJ, Barclay H, Chalmers JD. The microbiome in bronchiectasis. Eur Respir Rev. 2019;28:190048.","journal-title":"Eur Respir Rev"},{"key":"1634_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11046-017-0143-7","volume":"183","author":"SH Chotirmall","year":"2018","unstructured":"Chotirmall SH, Martin-Gomez MT. Aspergillus species in bronchiectasis: challenges in the cystic fibrosis and non-cystic fibrosis airways. Mycopathologia. 2018;183:45\u201359.","journal-title":"Mycopathologia"},{"key":"1634_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-016-1774-x","volume":"16","author":"L M\u00e1iz","year":"2016","unstructured":"M\u00e1iz L, Gir\u00f3n R, Olveira C, Vendrell M, Nieto R, Mart\u00ednez-Garc\u00eda MA. Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study. BMC Infect Dis. 2016;16:1\u20137. https:\/\/doi.org\/10.1186\/s12879-016-1774-x.","journal-title":"BMC Infect Dis"},{"key":"1634_CR14","first-page":"1602","volume":"12","author":"S Finch","year":"2015","unstructured":"Finch S, McDonnell MJ, Abo-Leyah H, Aliberti S, Chalmers JD. A comprehensive analysis of the impact of pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis. Ann Am Thorac Soc. 2015;12:1602\u201311.","journal-title":"Ann Am Thorac Soc"},{"key":"1634_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000339627","volume":"86","author":"D Vital","year":"2013","unstructured":"Vital D, Hofer M, Benden C, Holzmann D, Boehler A. Impact of sinus surgery on pseudomonal airway colonization, bronchiolitis obliterans syndrome and survival in cystic fibrosis lung transplant recipients. Respiration. 2013;86:25\u201331.","journal-title":"Respiration"},{"key":"1634_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/tid.12924","volume":"20","author":"LC Morlacchi","year":"2018","unstructured":"Morlacchi LC, Greer M, Tudorache I, Blasi F, Welte T, Haverich A, et al. The burden of sinus disease in cystic fibrosis lung transplant recipients. Transpl Infect Dis. 2018;20:1\u201311.","journal-title":"Transpl Infect Dis"},{"key":"1634_CR17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/alr.22067","volume":"8","author":"KJ Choi","year":"2018","unstructured":"Choi KJ, Cheng TZ, Honeybrook AL, Gray AL, Snyder LD, Palmer SM, et al. Correlation between sinus and lung cultures in lung transplant patients with cystic fibrosis. Int Forum Allergy Rhinol. 2018;8:389\u201393.","journal-title":"Int Forum Allergy Rhinol"},{"key":"1634_CR18","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/TP.0b013e31816651de","volume":"85","author":"P Botha","year":"2008","unstructured":"Botha P, Archer L, Anderson RL, Lordan J, Dark JH, Corris PA, et al. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation. 2008;85:771\u20134.","journal-title":"Transplantation"},{"key":"1634_CR19","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1097\/TP.0b013e318286e076","volume":"95","author":"SE Verleden","year":"2013","unstructured":"Verleden SE, Ruttens D, Vandermeulen E, Vaneylen A, Dupont LJ, Van Raemdonck DE, et al. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ? Transplantation. 2013;95:1167\u201372.","journal-title":"Transplantation"},{"key":"1634_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1183\/13993003.01968-2020","volume":"56","author":"AR Glanville","year":"2020","unstructured":"Glanville AR. Pseudomonas and risk factor mitigation for chronic lung allograft dysfunction. Eur Respir J. 2020;56:22\u20134.","journal-title":"Eur Respir J"},{"key":"1634_CR21","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12890-020-01299-0","volume":"20","author":"S Kumata","year":"2020","unstructured":"Kumata S, Hirama T, Watanabe Y, Oishi H, Niikawa H, Akiba M, et al. The fraction of sensitization among lung transplant recipients in a transplant center in Japan. BMC Pulm Med. 2020;20:256.","journal-title":"BMC Pulm Med"},{"key":"1634_CR22","doi-asserted-by":"publisher","first-page":"e562","DOI":"10.1097\/TXD.0000000000001013","volume":"6","author":"M Katahira","year":"2020","unstructured":"Katahira M, Hirama T, Eba S, Suzuki T, Notsuda H, Oishi H, et al. Impact of postoperative continuous renal replacement therapy in lung transplant recipients. Transplant Direct. 2020;6:e562.","journal-title":"Transplant Direct"},{"key":"1634_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12890-021-01442-5","volume":"21","author":"E Nikkuni","year":"2021","unstructured":"Nikkuni E, Hirama T, Hayasaka K, Kumata S, Kotan S, Watanabe Y, et al. Recovery of physical function in lung transplant recipients with sarcopenia. BMC Pulm Med. 2021;21:124.","journal-title":"BMC Pulm Med"},{"key":"1634_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1183\/20734735.0009-2019","volume":"15","author":"G Juliusson","year":"2019","unstructured":"Juliusson G, Gudmundsson G. Diagnostic imaging in adult non-cystic fibrosis bronchiectasis. Breathe. 2019;15:190\u20137.","journal-title":"Breathe"},{"key":"1634_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/978-3-319-74835-1_13","volume-title":"Infections of the ears, nose, throat, and sinuses","author":"AR Sedaghat","year":"2018","unstructured":"Sedaghat AR. Chronic Rhinosinusitis. In: Durand ML, Deschler DG, editors. Infections of the ears, nose, throat, and sinuses. Cham: Springer; 2018. p. 155\u201368."},{"key":"1634_CR26","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","volume":"38","author":"GM Verleden","year":"2019","unstructured":"Verleden GM, Glanville AR, Lease ED, Fisher AJ, Calabrese F, Corris PA, et al. Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment\u2014a consensus report from the Pulmonary Council of the ISHLT. J Heart Lung Transplant. 2019;38:493\u2013503. https:\/\/doi.org\/10.1016\/j.healun.2019.03.009.","journal-title":"J Heart Lung Transplant"},{"key":"1634_CR27","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1183\/09031936.05.00055705","volume":"26","author":"M Woodhead","year":"2005","unstructured":"Woodhead M, Blasi F, Ewig S, Huchon G, Ieven M, Leven M, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J. 2005;26:1138\u201380.","journal-title":"Eur Respir J"},{"key":"1634_CR28","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciaa241","volume":"71","author":"CL Daley","year":"2020","unstructured":"Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ, Andrejak C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline: executive summary. Clin Infect Dis. 2020;71:e1-36.","journal-title":"Clin Infect Dis"},{"key":"1634_CR29","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","volume":"24","author":"AJ Ullmann","year":"2018","unstructured":"Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018;24:e1-38.","journal-title":"Clin Microbiol Infect"},{"key":"1634_CR30","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1183\/09031936.00128607","volume":"31","author":"R Vos","year":"2008","unstructured":"Vos R, Vanaudenaerde BM, Geudens N, Dupont LJ, Van Raemdonck DE, Verleden GM. Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation? Eur Respir J. 2008;31:1037\u201345.","journal-title":"Eur Respir J"},{"key":"1634_CR31","doi-asserted-by":"publisher","first-page":"2001720","DOI":"10.1183\/13993003.01720-2020","volume":"56","author":"B De Muynck","year":"2020","unstructured":"De Muynck B, Van Herck A, Sacreas A, Heigl T, Kaes J, Vanstapel A, et al. Successful Pseudomonas aeruginosa eradication improves outcomes after lung transplantation: a retrospective cohort analysis. Eur Respir J. 2020;56:2001720.","journal-title":"Eur Respir J."},{"key":"1634_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-018-0634-4","volume":"18","author":"J Birch","year":"2018","unstructured":"Birch J, Sunny SS, Hester KLM, Parry G, Kate Gould F, Dark JH, et al. Outcomes of lung transplantation in adults with bronchiectasis. BMC Pulm Med. 2018;18:1\u20139.","journal-title":"BMC Pulm Med"},{"key":"1634_CR33","doi-asserted-by":"crossref","unstructured":"Kennedy J, Walker A, Ellender CM, Steinfort K, Martin C, Smith C, et al. Outcomes of non-cystic fibrosis related bronchiectasis post lung transplantation. Intern Med J. 2021.","DOI":"10.1111\/imj.15256"},{"key":"1634_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/tid.13229","volume":"22","author":"DZP Friedman","year":"2020","unstructured":"Friedman DZP, Cervera C, Halloran K, Tyrrell G, Doucette K. Non-tuberculous mycobacteria in lung transplant recipients: prevalence, risk factors, and impact on survival and chronic lung allograft dysfunction. Transpl Infect Dis. 2020;22:1\u20137.","journal-title":"Transpl Infect Dis"},{"key":"1634_CR35","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/tid.12546","volume":"18","author":"SK Shah","year":"2016","unstructured":"Shah SK, McAnally KJ, Seoane L, Lombard GA, LaPlace SG, Lick S, et al. Analysis of pulmonary non-tuberculous mycobacterial infections after lung transplantation. Transpl Infect Dis. 2016;18:585\u201391. https:\/\/doi.org\/10.1111\/tid.12546.","journal-title":"Transpl Infect Dis"},{"key":"1634_CR36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1399-3062.2012.00753.x","volume":"14","author":"BM Knoll","year":"2012","unstructured":"Knoll BM, Kappagoda S, Gill RR, Goldberg HJ, Boyle K, Baden LR, et al. Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study. Transpl Infect Dis. 2012;14:452\u201360. https:\/\/doi.org\/10.1111\/j.1399-3062.2012.00753.x.","journal-title":"Transpl Infect Dis"},{"key":"1634_CR37","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.healun.2018.06.008","volume":"37","author":"CA Aguilar","year":"2018","unstructured":"Aguilar CA, Hamandi B, Fegbeutel C, Silveira FP, Verschuuren EA, Ussetti P, et al. Clinical risk factors for invasive aspergillosis in lung transplant recipients: Results of an international cohort study. J Hear Lung Transplant. 2018;37:1226\u201334.","journal-title":"J Hear Lung Transplant"},{"key":"1634_CR38","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.jaip.2019.02.026","volume":"7","author":"E Handley","year":"2019","unstructured":"Handley E, Nicolson CH, Hew M, Lee AL. Prevalence and clinical implications of chronic rhinosinusitis in people with bronchiectasis: a systematic review. J Allergy Clin Immunol Pract. 2019;7:2004\u201312.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1634_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1055\/s-0037-1606600","volume":"22","author":"BF Ramos","year":"2018","unstructured":"Ramos BF, De Rezende Pinna F, Campos SV, Afonso J\u00fanior JE, De Oliveira Braga Teixeira RH, Carraro RM, et al. Assessment of pulmonary function before and after sinus surgery in lung transplant recipients. Int Arch Otorhinolaryngol. 2018;22:157\u201360.","journal-title":"Int Arch Otorhinolaryngol"},{"key":"1634_CR40","doi-asserted-by":"publisher","first-page":"192","DOI":"10.2500\/ajr.2008.22.3146","volume":"22","author":"M-K Leung","year":"2008","unstructured":"Leung M-K, Rachakonda L, Weill D, Hwang PH. Effects of sinus surgery on lung transplantation outcomes in cystic fibrosis. Am J Rhinol. 2008;22:192\u20136.","journal-title":"Am J Rhinol"},{"key":"1634_CR41","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1513\/AnnalsATS.201606-431OC","volume":"13","author":"SA Syed","year":"2016","unstructured":"Syed SA, Whelan FJ, Waddell B, Rabin HR, Parkins MD, Surette MG. Reemergence of lower-airway microbiota in lung transplant patients with cystic fibrosis. Ann Am Thorac Soc. 2016;13:2132\u201342.","journal-title":"Ann Am Thorac Soc"},{"key":"1634_CR42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.trre.2017.07.001","volume":"32","author":"JM Aguado","year":"2018","unstructured":"Aguado JM, Silva JT, Fern\u00e1ndez-Ruiz M, Cordero E, Fort\u00fan J, Gudiol C, et al. Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET\/GESITRA-SEIMC\/REIPI recommendations. Transplant Rev. 2018;32:36\u201357.","journal-title":"Transplant Rev"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-021-01634-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-021-01634-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-021-01634-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T03:50:46Z","timestamp":1673063446000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-021-01634-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,13]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1634"],"URL":"https:\/\/doi.org\/10.1186\/s12890-021-01634-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-499447\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,13]]},"assertion":[{"value":"6 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were performed in accordance with the Declaration of Helsinki. In light of the retrospective design, the requirement of informed consent was waived and the study protocol was approved by the Ethics Committee Tohoku University Graduate School of Medicine (Institutional Review Board number 2019-1-766). We disclosed information on the implementation of the research and ensured the opportunity for research subjects to refuse participation by posting the information disclosure materials approved by the Ethics Committee on the website of the Graduate School of Medicine, Tohoku University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"261"}}